The Magazine for Sleep Professionals
Friday, May 8, 2026
It’s well understood and accepted that sleep position, in particular the supine position in which a person sleeps on their back with their face and abdomen facing upwards, is associated with an increase in sleep-disordered breathing.1 While over half of all cases of obstructive sleep apnea (OSA) are classified as […]
The field of sleep health continues to expand into the acute care/inpatient environment. Over the years, more and more hospital leaders have started to see the importance of sleep as a vital component of the hospital experience. A recent scoping review undertaken by Suen et al. found that undiagnosed obstructive […]
– SynAIRgy Compares AD109 to Placebo Over 6 Months in People with OSA who Are Intolerant of or Refuse Positive Airway Pressure (PAP) Therapy, the Current Standard of Care – Part of a two-study registrational Phase 3 program that also includes LunAIRo which began enrollment in September 2023 Apnimed, Inc., […]
Aesyra, a medical device company pioneering oral appliance technologies to improve sleep, today announced it has raised $3 million in seed financing. The round was led by Supermoon Capital (USA), the world’s first fund focused on sleeptech, and deep tech investor Creadd Ventures (Switzerland) with participation from existing investor Zürcher […]
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, is pleased to announce that the publication of AEGIS clinical trial results is in press at the ERJ Open Research. The objective of the trial was to determine whether patients with mild obstructive sleep apnea (OSA) would […]
Nyxoah SA today announced that the Company has entered into a partnership with ResMed Germany to increase OSA awareness and therapy penetration in the German market. Nyxoah and ResMed Germany will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment. […]
Kingman Strohl, MD Obstructive sleep apnea (OSA) is effectively managed by positive airway pressure (PAP) applied to the nose and/or mouth. The principle of PAP is to inflate the critical region of closure in the upper airway, usually at the base of the tongue or the uvula. The effective property […]
By Regina Patrick, RPSGT, RST Obstructive Sleep Apnea and Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is a disorder in which many small fluid-filled sacs (i.e., cysts) develop on a woman’s ovaries and the ovaries produce high levels of male sex hormones (i.e., androgens). PCOS is also associated with insulin […]
By Snorri Helgason Introduction Sleep apnea has been identified as a serious health issue for most countries. It exerts a substantial influence on individuals’ physical and mental health, impairing daily functioning and overall quality of life if left untreated. Moreover, sleep apnea imposes a substantial burden on society, leading to […]
Inspire Medical Systems, Inc. has reported financial results and significant achievements for the quarter ended June 30, 2023. Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems, expressed satisfaction with the company’s performance in the second quarter. He attributed the growth to increased utilization at existing sites and […]
